Dental News - Vivos Therapeutics raises consumer awareness of its sleep apnea treatment

Dental Tribune International

Wed. 14. August 2019

save

DENVER, U.S./‎WILKES-BARRE, Pa., U.S.: Vivos Therapeutics, an American company that seeks to find the best evidence-based treatment for obstructive sleep apnea (OSA), has recently collaborated with one of the nation’s largest dental product and equipment distributors, Benco Dental, to promote the Vivos System apnea treatment in the U.S. and expand the company’s client base. As part of the partnership, Benco will offer its customers a unique in-person opportunity to obtain more information on the treatment and to find out how it benefits sleep apnea sufferers and dental practitioners in a series of events that will take place from October this year.

Sleep disorders, including sleep apnea, are a major health issue in the U.S. According to the American Sleep Apnea Association, approximately 22 million Americans suffer from sleep apnea and 80% of OSA cases are undiagnosed. “Sleep apnea is a serious and growing health epidemic facing America,” said Kirk Huntsman, CEO at Vivos. “Our newly formed partnership with Benco Dental will allow our revolutionary technology to reach dentists and their patients throughout the U.S. and introduce them to our VIP program designed specially to help clinicians achieve success, regardless of their experience levels in sleep dentistry.”

The Vivos System uses a proprietary variety of oral appliances to restore and reopen the upper airway without the patient having to undergo surgery. The procedure is completely noninvasive and does not require the patient to take any pharmaceutical drugs. At the beginning of the treatment, the patient is prescribed a custom-made oral appliance and is asked to wear it at night while sleeping. Patients can start seeing the results after 18 months of continued use.

“Our company has a long history of bringing to market innovative products from trailblazing companies,” said Chuck Cohen, Managing Director at Benco Dental. “The Vivos System stands as one of those potential game changers because it’s a possible curative solution—a technology-enabled, multidisciplinary, comprehensive solution—that dentists are uniquely qualified to apply. The Vivos vision of empowering clinicians to rid the world of OSA is keenly aligned with Benco’s own commitment to driving dentistry forward and opening new worlds of treatment possibilities,” he concluded.

More information about the treatment can be found here.

Tags:

One thought on “Vivos Therapeutics raises consumer awareness of its sleep apnea treatment”

Randall Crowell says:

December 22, 2019 at 4:43 am

amazing product

To post a reply please login or register

Interview: “Endodontic treatment is an invaluable therapeutic technique”

From 4 to 7 October, the world of endodontics will be meeting in the South Korean capital of Seoul for the 11th International Federation of Endodontic ...

Campaign to raise awareness of DIY orthodontics risks announced

GLASGOW, UK: At the recent British Orthodontic Conference in Glasgow, the British Orthodontic Society (BOS) and the Oral Health Foundation (OHF) have taken...

UK medical organisations team up to raise awareness of antibiotic overprescription

LONDON, UK: Antibiotic resistance is one of the key challenges that dental and medical professionals will face over the coming decades, yet its causes and ...

Accurate orthognathic surgery predictions for the obstructive sleep apnea patient

Orthognathic surgery has been performed routinely since the mid- 1970s to correct severe skeletal malocclusion. Since its inception, various forms of ...

Oral appliances may be highly effective in treating obstructive sleep apnea

NEW YORK, U.S.: Certain traits may define a type of obstructive sleep apnea (OSA) that can be effectively treated with an oral appliance, according to new ...

Mandibular movement monitoring may help improve oral sleep apnoea devices

NAMUR, Belgium: To date, continuous positive airway pressure is still the industry standard when it comes to treating sleep apnoea. However, the cumbersome ...

3Shape connects with sleep apnoea and bruxism device manufacturer SomnoMed

COPENHAGEN, Denmark: To offer a simpler, more effective and quicker workflow, 3Shape recently announced a new collaboration with sleep apparatus producer ...

Study raises awareness to mitigate diagnostic overshadowing in vulnerable patients in dentistry

LONDON, UK: A recent UK study has pointed to the need for education and awareness in dental teams to avoid diagnostic overshadowing—misattributing ...

Study reveals obstructive sleep apnoea as risk factor for COVID-19

TURKU, Finland: During the first wave of the pandemic, the number of hospitalisations for SARS-CoV-2 infections in Finland was relatively low compared with ...

Laser treatment of pulpal exposure to potentially avoid endodontic treatment

Pulpal exposures are unfortunately a routine occurrence when treating carious teeth and frequently lead to endodontic treatment owing to the size of the ...

Education

Live webinar
Mon. 29 September 2025
9:00 am EST (New York)